Abbvie Contract MFG

  Aseptic Fill Finish for Complex Drug Products Drugs conveyed through otic, ophthalmic, and parenteral routes have high risks of harm or infection. This is because they diverse many of the natural defenses in the body. To make sure patients are safe, the Food and Drug Administration demands that drug products conveyed through these paths be provided as sterile products.  This induction includes a lot of complex drug products, which include sterile injectables, ophthalmic suspension, aqueous-based aerosols (for inhalation), and lyophilized powders (injections) Our article talks about sterile lyophilization of drug products. To learn more about this, scroll down and keep reading.  Sterile Lyophilization of Duct Drug Products As big molecule formulations and drug products become popular, a large number of pharmaceutical formulations have challenges with solution stability and when this happens, there is impossibility of ready-to-use liquid dosage.  To fix this challeng...

Abbvie Drug Fill-Finish Products In the creation of an aseptic drug product, fill-finish is the last manufacturing step. Liquid filling in aseptic demands high technicians, ensuring that patients have safe and sterile products administered to them. At Abbvie, we offer GMP certified manufacturing capabilities. We process over a million vials annually with an automated filling line. Your drug product’s fill and finish procedures can be suited with customized packaging and labeling.  We have successfully advanced and distributed drug products for over 130 years, delivering products to more than 175 countries globally. There is no basis for the question as to whether or not we are excellent at what we do.  Terminal Sterilization  At Abbvie, our service package provides terminal sterilization. This includes a hundred percentage vial visual inspection with the use of labeling and packaging, polarized light, and batch certification.  We offer a very flexible service packag...